Middle East North Africa

US med-tech company begins restoration after cyber strike

Thu, 12 Mar 2026 12:00:00 -0400

Stryker Corp. is scrambling to recover from a cyberattack that’s disrupting its global network and being claimed by pro-Iranian hackers. “At this time, there is no indication of malware or ransomware, and we believe the situation is contained to our internal Microsoft environment only,” the Kalamazoo, Mich.-based med-tech company said March 12.

Icecure gets FDA nod for Prosense cryoablation in breast cancer

holland.johnson@clarivate.com — Mon, 06 Oct 2025 12:00:00 -0400

Icecure Medical Ltd. reported that the U.S. FDA has granted marketing authorization to Icecure's de novo application for the Prosense cryoablation system for the local treatment of breast cancer in patients 70 years of age or older with biologically low-risk tumors. The authorized indication includes patients that are not suitable for surgery for breast cancer treatment.

Mica AI looking to transform early breast cancer diagnosis

Tue, 03 Dec 2024 11:00:00 -0500

Mica AI Medical Ltd. is looking to transform the early diagnosis of breast cancer with its software which helps radiologists analyze mammograms more effectively. The company recently signed a collaboration and licensing agreement with Baptist Health South Florida in a bid to bring its technology to the U.S. market.

Momentis gains FDA clearance for second generation surgical robot

Tue, 12 Nov 2024 11:00:00 -0500

Momentis Surgical Ltd. received 510 (k) clearance from the U.S. FDA for the second-generation of the Anovo robotic surgical platform. The upgraded system allows surgeons to experience enhanced ergonomics with integrated haptic feedback, creating more intuitive control of the robotic arms during surgical procedures.

Epitomee swallows FDA clearance for weight loss capsule

Wed, 18 Sep 2024 12:00:00 -0400

Epitomee Ltd. happily swallowed the news of U.S. FDA clearance for its capsule for weight management, an ingestible medical device for adults who are overweight or obese. Designed for use along with diet and exercise, the capsule expands in the stomach to create a feeling of fullness that lasts up to six hours.

Summit expands rights, cash for Akeso’s China-approved NSCLC drug

Tue, 04 Jun 2024 12:00:00 -0400

Miami-headquartered Summit Therapeutics Inc. expanded rights to Akeso Inc.’s non-small-cell lung cancer (NSCLC) drug, ivonescimab (SMT-112; AK-112), June 3 while raising $200 million to advance the therapy.

Resilience overcomes war, capital challenges in Israel

Fri, 24 May 2024 12:00:00 -0400

Despite the ongoing war, speakers at Biomed Israel this week reported that business and investment in Israel’s med-tech industry continues largely unchanged.

Israeli accelerator to provide startups with $250,000 cash injection

Mon, 26 Feb 2024 11:00:00 -0500

Early-stage health care companies developing breakthrough medical technologies were given some good news recently with the launch of a new accelerator program by Israel’s Arc Innovation aimed at giving startups a $250,000 cash injection. With a $10 million investment from Ilex Medical Ltd., the initiative is looking to empower early-stage companies by providing financial backing, expert guidance and a support network.

Breathing-based system for detecting ADHD

Tue, 14 Nov 2023 11:00:00 -0500

Researchers from the Weizmann Institute of Science in Rehovot, Israel, are seeking – through the university’s commercial arm, Yeda Research and Development Co. Ltd. – to gain patent protection for methods and systems for detecting and treating attention deficit hyperactivity disorder (ADHD) that are based on nasal respiration parameters.

Israel tops up budget for struggling biotechs amid continuing war challenges

Tue, 07 Nov 2023 11:00:00 -0500

Negev reveals system for improved balance control, stroke rehab

Thu, 02 Nov 2023 12:00:00 -0400

Researchers from Israel’s Ben-Gurion University are seeking patent protection for a revamped mechatronic supported in-place walking training system, such as a stepper or elliptical trainer, that provides various types of expected and unexpected perturbations to improve balance control.

Israel tops up budget for struggling biotechs amid continuing war challenges

Wed, 01 Nov 2023 12:00:00 -0400

Israel’s finance ministry has increased the amount of funding high-tech companies with a short runway, including biotechs, can apply for under a fast-track scheme run by independent, publicly funded agency The Israel Innovation Authority, in response to the country’s war against Hamas. The program has been boosted by an extra ₪300 million (US$74.7 million), bringing the total budget to about ₪400 million, and from this month will assess applications from startups facing financial difficulties.

Little hype, strong results: progress in predicting, short-circuiting preeclampsia

Mon, 23 Oct 2023 12:00:00 -0400

Researchers may have figured out how to cut the hypertension that poses the most common threat in pregnancy.

Israeli med-tech companies adapt to wartime footing

Fri, 20 Oct 2023 12:00:00 -0400

In interviews with BioWorld, med-tech industry leaders in Israel noted upfront that a hasty exit mid-conversation could occur in response to sirens alerting to missile attacks. Despite constant disruption, most companies said they were determined to maintain business as close to usual as possible. Still, challenges abound, including the potential mandatory military activation of CEO and key personnel, ongoing attacks and potential disruption or diversion of critical resources. The tenor remains positive, however, with companies praising strong support from the venture capital community and other investors and partners worldwide and the benefits of operations in the U.S.

Patent update: Zero Candida Ltd. showcases its intravaginal light-based treatment device for vaginal disorders

Mon, 25 Sep 2023 09:00:00 -0400

The co-founders of Zero Candida Ltd. described, in the company’s first PCT filing, their development of a drug-free solution for treating vaginal fungal infections using an intravaginal light-based treatment device (ILTD) that projects light at predefined intervals and intensities to treat infection.

Patent update: Neuroderm improves the design for its wearable anti-Parkinson’s infusion pump

Wed, 20 Sep 2023 09:00:00 -0400

The latest patent application from Neuroderm Ltd. described a magnetic coupling and detection mechanism for its small two-part wearable infusion drug delivery device that delivers a liquid drug to Parkinson’s disease patients subcutaneously.

Briya raises $11.5M to expand health care data exchange platform

Tue, 19 Sep 2023 12:00:00 -0400

Israeli startup Briya Ltd. raised $11.5 million in series A financing which will support the expansion of its health care data exchange platform across Europe and the U.S. The round was led by Team8, and included existing investors Insight Partners, and Amiti Ventures, and was joined by the George Kaiser Family Foundation.

Nemaura raises $6.5M, eyes Saudi diabetes market

Fri, 08 Sep 2023 12:00:00 -0400

Nemaura Medical Inc. recently raised $6.5 million in non-dilutive funding through a clean debt facility with no warrants or convertible elements. The funding came from its existing lender and is expected to fund Nemaura’s ongoing efforts to commercialize its daily disposable, wearable glucose sensors.

Shoni Health Ventures launches fund for startups focusing on digital health and medical devices

Thu, 29 Jun 2023 12:00:00 -0400

Israeli venture capital fund, Shoni Health Ventures, launched a new fund focused on startups specializing in digital health and medical devices. Recognizing that innovative solutions with the potential to improve global health may go unrealized as health tech startups struggle to attract early-stage investors, the fund is focused on investing in companies at the pre-seed and seed-stage.

Truleaf ready to begin human trials of two-stage TMVR platform

Wed, 08 Feb 2023 13:00:00 -0500

Truleaf Medical Ltd., a subsidiary of Israel-based Allmed Solutions, is ready to begin human trials of its Rosedoc platform to replace the heart’s leaky mitral valve using cardiac catheterization.

Synchrony targets US market for airway clearance system

Tue, 05 Jul 2022 13:00:00 -0400

Israeli startup Synchrony Medical Ltd. is gearing up to begin a U.S. clinical trial testing an airway clearance method developed at Israel’s Sheba Medical Center. The Libairty device is designed to support chronic lung disease patients to clear mucus with a short home-based daily treatment.

A fertile field: Aivf raises $25M as Fairtility receives CE mark

Tue, 05 Jul 2022 13:00:00 -0400

Two Israeli companies aiming to improve in vitro fertilization (IVF) success rates received good news recently, with Aivf Ltd. hauling in $25 million in a series A round for Ema, its IVF software platform, and Fairtility Ltd. gaining CE mark for its CHLOE EQ embryo quality decision-support tool.

Fairtility births $15M series A funding round

Mon, 23 May 2022 13:00:00 -0400

Proving that reproduction remains a fecund market for investment, Israeli startup Fairtility Ltd. closed a $15 million series A funding round. Led by Boston-based Gurnet Point Capital with support from Nacre Capital and others, the round boosted Fairtility’s funding to date up to $18.5 million.

AI-focused innovation lab aims to advance antibody discovery

Fri, 13 May 2022 13:00:00 -0400

Pharma and tech companies including Amazon Inc., Astrazeneca plc, Pfizer Inc., Merck & Co. Inc. and Teva Inc. are partnering with an innovation lab based in Israel to accelerate artificial intelligence (AI) driven antibody discovery. Rehovot, Israel-based Aion Labs recently launched a venture hub for innovators and scientists from around the world.

Can Memic mimic robotics success on the market?

Thu, 12 May 2022 13:00:00 -0400

Following the termination of a planned merger with SPAC Medtech Acquisition Corp., Tel Aviv-based Memic Innovative Surgery Ltd. is looking to slowly roll out its Hominis surgical platform. Nasdaq-listed SPAC Medtech and Memic called off the agreement due to “market volatility and world events.”

From promise to execution, digital health innovators reach for new heights

Wed, 11 May 2022 13:00:00 -0400

In the post COVID world, digital transformation is at the forefront of every company’s agenda, but which innovations can fuel the next era of health care? At the ongoing Biomed Israel conference in Tel Aviv, Anat Naschitz founder and CEO of 9xchange and co-founder of Orbimed Israel, lead a digital health track exploring the technologies aiming to reconstruct the future of health care.

Medtech 2032: Where is the industry heading?

Tue, 10 May 2022 13:00:00 -0400

Ten years from now, what medical technologies will generate the most economic value and where is the industry heading? At the annual Biomed Israel conference, held in Tel Aviv, health care, pharmaceutical and technology advisor, and board director Sandra Morgan examined research from consulting firm McKinsey & Co. and beyond on the biggest innovation trends in the sector.

Israeli med-tech innovators told to adapt strategy or face no exit

Tue, 10 May 2022 13:00:00 -0400

At the annual Biomed Israel conference, held in Tel Aviv, Eyal Lifschitz, co-founder of Israeli venture capital fund Peregrine Venture, urged entrepreneurs to adapt their business strategy or face a long, difficult road to exit. With strategic companies increasingly favoring companies later in development, Lifschitz advised innovators to expand their vision beyond the traditional buyers.

Israeli startups eye growing precision oncology market

Mon, 09 May 2022 13:00:00 -0400

With cancer treatment success rates rising, the field of precision oncology is poised to grow as clinicians aim to move treatment from a one size fits all approach to personalized treatment regimens. Israeli startups including Oncohost Ltd., Nucleai Ltd. and Gina Life Diagnostics Ltd. are part of an emerging wave of companies utilizing artificial intelligence (AI) and machine learning (ML) techniques to personalize the future of cancer diagnostics.

Newstem files for haploid human embryonic stem cell-based diagnostic

Tue, 12 Apr 2022 13:00:00 -0400

Newstem Ltd. filed a presubmission to the U.S. FDA for a de novo request and an in vitro diagnostic device with the EMA for its Newstem software diagnostic device (NSDD). The bioinformatics-based platform is a personalized diagnostic to inform oncologists about the presence of mutations in tumors and predict a patients’ resistance to chemotherapy treatments. The technology utilizes specialized stem cells (haploid cells) that carry just one set of chromosomes.